Santa Ana Bio

About Santa Ana Bio

Santa Ana Bio utilizes multi-omics platforms and antibody engineering to develop precision therapies for patients with autoimmune and inflammatory diseases. The company focuses on delivering targeted treatments that address the underlying immune mechanisms driving these conditions.

```xml <problem> Autoimmune and inflammatory diseases are complex conditions driven by underlying immune mechanisms that are not always effectively addressed by current treatments. Existing therapies may lack precision, leading to off-target effects and suboptimal outcomes for patients. </problem> <solution> Santa Ana Bio is developing precision therapies for autoimmune and inflammatory diseases by integrating multi-omics platforms with antibody engineering. This approach allows for the identification of specific immune drivers and the creation of targeted treatments designed to modulate these mechanisms. By focusing on the root causes of immune-mediated diseases, Santa Ana Bio aims to deliver more effective and personalized therapies. </solution> <features> - Multi-omics platform for comprehensive immune profiling - Antibody engineering capabilities for creating targeted therapeutics - Focus on precision medicine for autoimmune and inflammatory diseases </features> <target_audience> The primary target audience includes patients with autoimmune and inflammatory diseases, as well as healthcare providers specializing in immunology and related fields. </target_audience> ```

What does Santa Ana Bio do?

Santa Ana Bio utilizes multi-omics platforms and antibody engineering to develop precision therapies for patients with autoimmune and inflammatory diseases. The company focuses on delivering targeted treatments that address the underlying immune mechanisms driving these conditions.

Where is Santa Ana Bio located?

Santa Ana Bio is based in Alameda, United States.

When was Santa Ana Bio founded?

Santa Ana Bio was founded in 2022.

How much funding has Santa Ana Bio raised?

Santa Ana Bio has raised 203020000.

Location
Alameda, United States
Founded
2022
Funding
203020000
Employees
39 employees
Major Investors
Google Ventures
Looking for specific startups?
Try our free semantic startup search

Santa Ana Bio

Score: 100/100
AI-Generated Company Overview (experimental) – could contain errors

Executive Summary

Santa Ana Bio utilizes multi-omics platforms and antibody engineering to develop precision therapies for patients with autoimmune and inflammatory diseases. The company focuses on delivering targeted treatments that address the underlying immune mechanisms driving these conditions.

santaanabio.com2K+
cb
Crunchbase
Founded 2022 – Alameda, United States

Funding

$

Estimated Funding

$203M+

Major Investors

Google Ventures

Team (30+)

No team information available. Click "Fetch founders" to run a focused founder search.

Company Description

Problem

Autoimmune and inflammatory diseases are complex conditions driven by underlying immune mechanisms that are not always effectively addressed by current treatments. Existing therapies may lack precision, leading to off-target effects and suboptimal outcomes for patients.

Solution

Santa Ana Bio is developing precision therapies for autoimmune and inflammatory diseases by integrating multi-omics platforms with antibody engineering. This approach allows for the identification of specific immune drivers and the creation of targeted treatments designed to modulate these mechanisms. By focusing on the root causes of immune-mediated diseases, Santa Ana Bio aims to deliver more effective and personalized therapies.

Features

Multi-omics platform for comprehensive immune profiling

Antibody engineering capabilities for creating targeted therapeutics

Focus on precision medicine for autoimmune and inflammatory diseases

Target Audience

The primary target audience includes patients with autoimmune and inflammatory diseases, as well as healthcare providers specializing in immunology and related fields.